Delivery Order SPE2DB20D3103-SPE2DB23FN9S6
Award Date
7/12/23
Potential Completion Date
7/13/23
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,693.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 300ML. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,257.04, is for the delivery of the pharmaceutical product "KONVOMEP 2-84 MG/ML ORAL SUSP 300ML" and has a completion date of April 15, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,233.05, is a delivery order under a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $1,399.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a pharmaceutical product, under a Firm Fixed Price contract type. The contract has an ultimate completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (DO) valued at $2,912.78 issued by the Defense Logistics Agency (DLA). The award is for the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, which is a medical supply for use by the U.S. government. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,782.68 firm-fixed-price delivery order is for the provision of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,616.87 Firm Fixed Price Delivery Order is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 6, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,492.96, is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product, with a completion date of December 14, 2023. The contract is a Delivery Order and has a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,522.74 firm fixed-price delivery order is for the supply of KONVOMEP 2-84 MG/ML oral suspension in 300 ml bottles, with a completion date of February 20, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,042.18, is a Firm Fixed Price Delivery Order to provide KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a pharmaceutical product. The award has an ultimate completion date of December 10, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a...